Results 151 to 160 of about 115,857 (253)

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

open access: yesHaematologica, 2017
Elizabeth Margolskee   +3 more
doaj   +1 more source

Assessment of the Performance of Siemens Scopio Digital Morphology on Bone Marrow Aspirates in Onco‐Hematology

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1000-1007, October 2026.
ABSTRACT Objectives Digital morphology (DM) systems assisted by artificial intelligence are increasingly being introduced into hematology laboratories; however, data on their performance in routine clinical practice for bone marrow aspirates (BMA) remain limited.
Gina Zini   +6 more
wiley   +1 more source

Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population

open access: yesClinics, 2013
OBJECTIVE: The JAK2 46/1 haplotype has recently been described as a major contributing factor to the development of myeloproliferative neoplasm, whether positive or negative forthe JAK2 V617F mutation.
Sarah Pagliarini-e-Silva   +6 more
doaj  

Immunophenotypic, Genetic, and Clinical Features Associated With RUNX1 Mutation in Acute Leukemias and Chronic Myeloid Neoplasms

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1094-1102, October 2026.
ABSTRACT Introduction RUNX1 is a commonly mutated transcriptional regulator of hematopoiesis in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Mutated RUNX1 (mRUNX1) may associate with cross‐lineage immunophenotypic aberrancy, presenting potential complications for blast lineage assignment at diagnosis. Methods Clinical and laboratory
Yi Han Xia, Eric McGinnis
wiley   +1 more source

An agenda for future research projects in polycythemia vera and essential thrombocythemia

open access: yesHaematologica, 2020
Tiziano Barbui   +4 more
doaj   +1 more source

Genomic Evolution of Myeloproliferative Neoplasms and Therapy-Associated Mutagenesis. [PDF]

open access: yesCancer Discov
Leongamornlert D   +18 more
europepmc   +1 more source

Cytogenetic Diversity of Variant Philadelphia Translocations in Chronic Myeloid Leukemia

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1103-1112, October 2026.
ABSTRACT Introduction Chronic myeloid leukemia (CML) is a disease characterized by Philadelphia (Ph) translocations. These translocations can be classical or variant. The structural features and diagnostic implications of variant Philadelphia translocations remain incompletely defined, and they display considerable cytogenetic heterogeneity. Methods In
Ayse Gul Bayrak Tokac   +10 more
wiley   +1 more source

Are thrombosis, progression, and survival in ET predictable?

open access: yesBlood Cancer Journal
Ghaith Abu-Zeinah   +7 more
doaj   +1 more source

The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism

open access: yes
HemaSphere, Volume 10, Issue 10, October 2026.
Charlotte Lees   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy